首页> 中文期刊> 《中国药理学与毒理学杂志 》 >酒石酸长春瑞滨对大鼠免疫和造血系统的长期毒性作用

酒石酸长春瑞滨对大鼠免疫和造血系统的长期毒性作用

             

摘要

目的:从病理学角度研究酒石酸长春瑞滨( NVB)对大鼠免疫和造血系统的长期毒性作用。方法48只 SD 大鼠,雌雄各半,随机分为正常对照组和 NVB 5.0,10.0和20.0 mg·m-2组。NVB 静脉滴注给药,第1和第8天各给药1次,21 d 为1个周期,共给药4个周期。末次给药后14 d 腹主动脉取血,用ADVIA2120血液分析仪检测白细胞(WBC)、中性粒细胞(Neut)、淋巴细胞(Lym)和红细胞(RBC)数及网织红细胞千分比值(RET‰);剖取胸腺、胸骨骨髓、脾和肠系膜淋巴结进行组织病理学检查;精密称取胸腺和脾质量,计算脏器系数;取出股骨骨髓,进行骨髓涂片分类计数。结果与正常对照组比较,NVB 5.0,10.0和20.0 mg·m-2组雌雄大鼠外周血中 WBC,Neut,Lym 和 RBC 数及 RET‰均降低(P﹤0.05,P﹤0.01),其中雄性大鼠正常对照组 Neut 为(2.35±0.56)×109 L-1,NVB 各组分别降低为(1.66±0.44),(0.67±0.22)和(0.20±0.02)×109 L-1;雌性大鼠正常对照组 Neut 为(1.26±0.27)×109 L-1,NVB 各组分别降低为(1.14±0.56),(0.47±0.13)和(0.21±0.08)×109 L-1。骨髓涂片分类计数结果显示,粒系细胞比例降低( P ﹤0.05, P﹤0.01),其中雄性大鼠正常对照组粒系百分比为(42.7±6.1)%,NVB 各组分别降低为(28.8±5.3)%,(22.0±3.2)%和(18.9±3.9)%;雌性大鼠正常对照组粒系百分比为(35.4±3.0)%,NVB 各组分别降低为(31.2±4.7)%,(22.9±6.7)%和(20.8±4.2)%。胸腺系数降低(P﹤0.05,P﹤0.01),其中雄性大鼠正常对照组为0.36±0.04,NVB 各组分别降低为0.31±0.06,0.18±0.03和0.08±0.01;雌性大鼠正常对照组为0.29±0.06,NVB 各组分别降低为0.25±0.06,0.19±0.06和0.07±0.01。组织病理学检查结果显示,NVB 5.0,10.0和20.0 mg·m-2可致雌雄大鼠不同程度的胸腺萎缩和骨髓造血抑制,NVB 各剂量组亦可见不同程度的脾代偿性髓外造血细胞增多,肠系膜淋巴结均未见明显病理改变。结论 NVB 对 SD 大鼠免疫和造血系统具有毒性作用,表现为胸腺萎缩和骨髓造血抑制。%OBJECTlVE To study the Iong term toxicity of vinoreIbine tartrate(NVB)on rat immune and hematopoietic systems pathoIogicaIIy. METHODS SD Rats were randomIy divided into 4 groups:normaI controI group and NVB 5.0,10.0,and 20.0 mg·m-2 groups,each group containing 6 maIe and femaIe rats. The rats in NBV groups were administered different concentrations of NVB by intravenous drip on the 1st and 8th days,21 da cycIe,for 4 cycIes. On the 14th day after the Iast administration, white bIood ceIIs(WBC),neutrophiI(Neut),Iymphocytes(Lym),red bIood ceIIs(RBC)and reticuIo-cyte‰(RET‰)were detected by ADVIA2120 hematoIogy anaIyzer. Thymus,sternum marrow,spIeen and mesenteric Iymph nodes were observed by histopathoIogicaI examination. The thymus and spIeen were preciseIy weighed to obtain the reIative organ coefficients. Bone marrow smears were made for counting and cIassification. RESULTS Compared with normaI controI group,WBC,Neut,Lym,RBC and RET% of peripheraI bIood of NVB 5,10 and 20 mg·m-2 groups were decreased(P﹤0.05,P﹤0.01). The Neut vaIue of maIe rats was(2.35±0.56)×109·L-1 in normaI controI group,but was reduced to (1.66±0.44),(0.67±0.22)and(0.20±0.02)×109·L-1(P﹤0.05,P﹤0.01)in NVB 5,10 and 20 mg·m-2 groups. The Neut vaIue of femaIe rats was(1.26± 0.27)× 109 L-1 in normaI controI group,but was reduced to(1.14±0.56),(0.47±0.13)and(0.21±0.08)×109 L-1(P﹤0.05,P﹤0.01)in NVB 5,10 and 20 mg·m-2 groups. The resuIts of counting and cIassification of bone marrow smears showed that the myeIoid ceII ratio decreased(P﹤0.05,P﹤0.01). The myeIoid ceII ratio of maIe rats was(42.7±6.1)% in normaI controI group,but was reduced to(28.8±5.3)%,(22.0±3.2)% and(18.9±3.9)% in NVB 5,10 and 20 mg·m-2 groups. The myeIoid ceII ratio of femaIe rats in normaI controI group was(35.4±3.0)%, but was reduced to(31.2±4.7)%,(22.9±6.7)% and(20.8±4.2)% in NVB 5,10 and 20 mg·m-2 groups. The thymus coefficient was reduced(P﹤0.05,P﹤0.01). The thymus coefficient of maIe rats in normaI controI group was 0.36±0.04,but was reduced to 0.31±0.06,0.18±0.03 and 0.08±0.01 in NVB 5,10 and 20 mg·m-2 groups. The thymus coefficient of femaIe rats in normaI controI group was 0.29±0.06,but was reduced to 0.25±0.06,0.19±0.06 and 0.07±0.01 in NVB 5,10 and 20 mg·m-2 groups. Histopatho-IogicaI examination showed that thymus was atrophiedand bone marrow was suppressed. SpIeen com-pensatory extrameduIIary hematopoietic ceIIs were increased in NVB 5.0,10.0 and 20.0 mg·m-2 groups (maIe and femaIe)to different degrees,but the mesenteric Iymph nodes of NVB groups showed no sig-nificant pathoIogicaI changes. CONCLUSlON NVB has immune and hematopoietic toxicity on SD rats, as is showed by thymic atrophy and bone marrow suppression.

著录项

  • 来源
    《中国药理学与毒理学杂志 》 |2014年第4期|562-568|共7页
  • 作者单位

    天津药物研究院新药安全评价研究中心病理室;

    天津 300193;

    天津药物研究院新药安全评价研究中心病理室;

    天津 300193;

    天津药物研究院新药安全评价研究中心病理室;

    天津 300193;

    天津药物研究院新药安全评价研究中心病理室;

    天津 300193;

    天津药物研究院新药安全评价研究中心病理室;

    天津 300193;

    天津药物研究院新药安全评价研究中心病理室;

    天津 300193;

    天津药物研究院新药安全评价研究中心病理室;

    天津 300193;

    天津药物研究院新药安全评价研究中心病理室;

    天津 300193;

    天津药物研究院新药安全评价研究中心病理室;

    天津 300193;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 中药药性学 ;
  • 关键词

    酒石酸长春瑞滨; 免疫系统 ; 造血器官 ; 毒性 ;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号